These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 26435499

  • 1. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
    Dai Y, Duan H, Duan C, Zhou R, He Y, Tu Q, Shen L.
    Biochem Biophys Res Commun; 2016 Jan 15; 469(3):430-6. PubMed ID: 26435499
    [Abstract] [Full Text] [Related]

  • 2. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
    Hong SN, Kim SJ, Kim ER, Chang DK, Kim YH.
    J Gastroenterol Hepatol; 2016 Jan 15; 31(1):164-71. PubMed ID: 26250123
    [Abstract] [Full Text] [Related]

  • 3. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
    Ma SS, Srivastava S, Llamosas E, Hawkins NJ, Hesson LB, Ward RL, Ford CE.
    BMC Cancer; 2016 Jul 20; 16():508. PubMed ID: 27440078
    [Abstract] [Full Text] [Related]

  • 4. Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinoma.
    Moon JW, Choi JH, Lee SK, Lee YW, Lee JO, Kim N, Lee HJ, Seo JS, Kim J, Kim HS, Kim GJ, Park SH.
    Cancer Genet; 2015 May 20; 208(5):261-70. PubMed ID: 26002729
    [Abstract] [Full Text] [Related]

  • 5. TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.
    Gooskens SL, Klasson TD, Gremmels H, Logister I, Pieters R, Perlman EJ, Giles RH, van den Heuvel-Eibrink MM.
    Mol Oncol; 2018 Feb 20; 12(2):166-179. PubMed ID: 29080283
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
    Kang XC, Chen ML, Yang F, Gao BQ, Yang QH, Zheng WW, Hao S.
    Biomed Pharmacother; 2016 May 20; 80():23-29. PubMed ID: 27133036
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.
    Cao B, Yang Y, Pan Y, Jia Y, Brock MV, Herman JG, Guo M.
    Discov Med; 2013 Oct 20; 16(88):137-47. PubMed ID: 24099668
    [Abstract] [Full Text] [Related]

  • 11. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
    Zhang Y, Wang X, Xu B, Wang B, Wang Z, Liang Y, Zhou J, Hu J, Jiang B.
    Oncol Rep; 2013 Oct 20; 30(4):1976-84. PubMed ID: 23900443
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT, Wang JL, Du W, Hong J, Zhao SL, Wang YC, Xiong H, Chen HM, Fang JY.
    Carcinogenesis; 2011 Aug 20; 32(8):1207-15. PubMed ID: 21665895
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
    Han F, Liu W, Jiang X, Shi X, Yin L, Ao L, Cui Z, Li Y, Huang C, Cao J, Liu J.
    Oncogene; 2015 Aug 13; 34(33):4391-402. PubMed ID: 25435374
    [Abstract] [Full Text] [Related]

  • 15. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
    Boughanem H, Pilo J, García-Flores LA, Arranz I, Ramos-Fernandez M, Ortega-Castan M, Crujeiras AB, Sandoval J, Macias-Gonzalez M.
    J Transl Med; 2024 May 27; 22(1):509. PubMed ID: 38802858
    [Abstract] [Full Text] [Related]

  • 16. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
    Xiang S, Xiang T, Xiao Q, Li Y, Shao B, Luo T.
    Int J Oncol; 2017 Sep 27; 51(3):801-811. PubMed ID: 28677721
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic silencing of diacylglycerol kinase gamma in colorectal cancer.
    Kai M, Yamamoto E, Sato A, Yamano HO, Niinuma T, Kitajima H, Harada T, Aoki H, Maruyama R, Toyota M, Hatahira T, Nakase H, Sugai T, Yamashita T, Toyota M, Suzuki H.
    Mol Carcinog; 2017 Jul 27; 56(7):1743-1752. PubMed ID: 28218473
    [Abstract] [Full Text] [Related]

  • 18. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.
    J Natl Cancer Inst; 2009 Jul 01; 101(13):916-27. PubMed ID: 19535783
    [Abstract] [Full Text] [Related]

  • 19. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
    Jin H, Li T, Ding Y, Deng Y, Zhang W, Yang H, Zhou J, Liu C, Lin J, Ding Y.
    Hum Pathol; 2011 Apr 01; 42(4):541-51. PubMed ID: 21237486
    [Abstract] [Full Text] [Related]

  • 20. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
    Gao X, Tang C, Shi W, Feng S, Qin W, Jiang T, Sun Y.
    Int J Clin Exp Pathol; 2015 Apr 01; 8(10):12766-74. PubMed ID: 26722466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.